SC
IRON icon

Stephens Consulting’s Disc Medicine IRON Stock Holding History

Stephens Consulting’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$497 – 1578
2025
Q1 		$497 Buy
+10
New +$556 ﹤0.01% 923

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stephens Consulting's IRON Position: Q2 2025 in Review

Stephens Consulting sold out of Disc Medicine (IRON) in Q2 2025, closing a stake of 10 shares — an estimated $497 sold.

Stephens Consulting first reported a position in IRON in Q1 2025 and held it in 1 quarter. The position peaked at $497 in Q1 2025. 151 funds tracked by Wall St. Rank hold IRON as of Q2 2025.

  • Stephens Consulting reported no remaining Disc Medicine position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 10 Disc Medicine shares in Q2 2025, an estimated $497.
  • Stephens Consulting first reported a position in Disc Medicine in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's Disc Medicine position peaked at $497 in Q1 2025.
  • 151 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.